6-Hexanolactone structure
|
Common Name | 6-Hexanolactone | ||
|---|---|---|---|---|
| CAS Number | 502-44-3 | Molecular Weight | 114.142 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 225.4±8.0 °C at 760 mmHg | |
| Molecular Formula | C6H10O2 | Melting Point | -1 °C | |
| MSDS | Chinese USA | Flash Point | 109.4±0.0 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | hexano-6-lactone |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 225.4±8.0 °C at 760 mmHg |
| Melting Point | -1 °C |
| Molecular Formula | C6H10O2 |
| Molecular Weight | 114.142 |
| Flash Point | 109.4±0.0 °C |
| Exact Mass | 114.068077 |
| PSA | 26.30000 |
| LogP | 0.36 |
| Vapour density | 3.9 (vs air) |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.439 |
| InChIKey | PAPBSGBWRJIAAV-UHFFFAOYSA-N |
| SMILES | O=C1CCCCCO1 |
| Water Solubility | >1000 MG/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319 |
| Precautionary Statements | P280-P305 + P351 + P338-P337 + P313 |
| Personal Protective Equipment | Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/38 |
| Safety Phrases | S26-S39-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | MO8400000 |
| HS Code | 2932209090 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2932209090 |
|---|---|
| Summary | 2932209090. other lactones. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
J. Biomater. Appl. 29(4) , 524-42, (2014) Anti-tumor necrosis factor α (TNFα) drugs such as etanercept (ETN) have been mostly used in systemic treatment of rheumatoid arthritis. To eliminate the side effects in long-term treatments and to ach... |
|
|
The imaging and the fractal metrology of chimeric liposomal Drug Delivery nano Systems: the role of macromolecular architecture of polymeric guest.
J. Liposome Res. 24(3) , 223-9, (2014) The major advance of mixed liposomes (the so-called chimeric systems) is to control the size, structure, and morphology of these nanoassemblies, and therefore, system colloidal properties, with the ai... |
|
|
Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles.
Eur. J. Pharm. Biopharm. 88(1) , 75-84, (2014) Drug delivery into hair follicles with the use of nanoparticles (NPs) is gaining more importance as drug-loaded NPs may accumulate in hair follicle openings. The aim was to develop and evaluate a plur... |
| Oxepan-2-on |
| ε-Caprolactone |
| 6-hydroxyhexanoic acid, ε-lactone |
| E-CAPROLACTONE |
| e-Hexanolactone |
| ε-Hexanolactone |
| UNII-56RE988L1R |
| 6-Caprolactone monomer |
| ε-Hexalactone |
| 6-hydroxyhexanoic acid lactone |
| EINECS 207-938-1 |
| 6-Hexanolactone |
| 2-Oxepanone |
| Hexanoic acid, ε-lactone |
| caprolactone |
| oxepan-2-one |
| Epsilon-Caprolactone Monomer |
| MFCD00003267 |
| Hexamethylene oxide, 2-oxo- |
| 1,6-hexanolide |